Actinium Pharmaceuticals Inc (ATNM)

Actinium Pharmaceuticals Inc Stock (ATNM) Forecast

The Actinium Pharmaceuticals Inc (ATNM) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.8266, representing a -48.01% decrease from the current price of $1.59. The highest analyst price target is $1.53, and the lowest is $0.1185.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month ATNM Price Target

Average 1.70 (+7.21% Downside)

Is Actinium Pharmaceuticals Inc (ATNM) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	63.08	Neutral
STOCH(9,6)	63.81	Neutral
STOCHRSI(14)	91.58	Sell
MACD(12,26)	0.09	Buy
ADX(14)	32.09	Buy
William %R	-16.22	Sell
CCI(14)	66.93	Neutral

Buy: 2 · Sell: 2 · Neutral: 3Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	1.47 Buy	1.50 Buy
MA20	1.44 Buy	1.42 Buy
MA50	1.27 Buy	1.29 Buy
MA100	1.11 Buy	1.21 Buy
MA200	1.13 Buy	1.22 Buy

Buy: 10 · Sell: 0 · Neutral: 0Summary: Buy

According to our latest analysis, ATNM could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 2 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on ATNM, as trading bullish markets is always a lot easier

RSI (Relative Strength Index): The RSI(14) value of 63.08 indicates that ATNM is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 63.81 indicates that ATNM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 91.58 indicates that ATNM is overbought. This suggests that ATNM price is at or near the highest level relative to its recent price history.
ADX (Average Directional Index): The ADX value of 32.09 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
CCI (Commodity Channel Index): A CCI(14) value of 66.93 indicates that ATNM is still overbought but not to an extreme extent.

Long-term ATNM price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Actinium Pharmaceuticals Inc financial reports and earnings history, Actinium Pharmaceuticals Inc (ATNM) stock could reach $1.78 by 2030, $7.57 by 2040 and $22.02 by 2050. See the projected annual prices until 2050 of the Actinium Pharmaceuticals Inc stock below:

Actinium Pharmaceuticals Inc (ATNM) is expected to reach an average price of $4.84 in 2035, with a high prediction of $4.77 and a low estimate of $0.0456. This indicates an +204.68% change from the last recorded price of $1.59.
Actinium Pharmaceuticals Inc (ATNM) stock is projected to chart a bullish course in 2040, with an average price target of $2.00, representing an +25.57% change from its current level. The forecast ranges from a conservative $2.60 to a sky-high $7.57.
Our analysts predict Actinium Pharmaceuticals Inc (ATNM) to change +579.46% by 2045, soaring from $6.73 to an average price of $10.80, potentially reaching $11.14. While $6.73 is the low estimate, the potential upside is significant.
Actinium Pharmaceuticals Inc (ATNM) stock is expected to climb by 2050, reaching an average of $13.71, a +762.36% change from its current level. However, a wide range of estimates exists, with high and low targets of $22.02 and $11.55, respectively, highlighting the market's uncertainty.

Actinium Pharmaceuticals Inc Stock (ATNM) Year by Year Forecast

Actinium Pharmaceuticals Inc Stock (ATNM) Price Forecast for 2026

The predicted value for Actinium Pharmaceuticals Inc (ATNM) in 2026 is set at an average of $1.09. Estimates vary from a peak of $2.22 to a trough of $0.1185, indicating an -31.65% surge from the present price of $1.59.

Month	Average	Low	High	Change from today's price
December, 2026	$0.7271	$0.1185	$1.53	-54.27%

Actinium Pharmaceuticals Inc Stock (ATNM) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Actinium Pharmaceuticals Inc (ATNM) is $1.30, with a high forecast of $10.03 and a low forecast of $0.0167. This indicates an -18.29% decrease from the last price of $1.59.

Month	Average	Low	High	Change from today's price
January, 2027	$0.5182	$0.0368	$0.9231	-67.41%
February, 2027	$0.7435	$0.7758	$0.3235	-53.24%
March, 2027	$0.9227	$0.7541	$0.6227	-41.97%
April, 2027	$0.528	$0.638	$0.4124	-66.79%
May, 2027	$0.1429	$0.0167	$1.86	-91.01%
June, 2027	$0.00762	$0.1174	$0.7953	-99.52%
July, 2027	$0.3377	$0.1962	$0.2738	-78.76%
August, 2027	$0.5268	$0.4627	$0.3553	-66.87%
September, 2027	$0.5779	$0.0183	$0.8979	-63.65%
October, 2027	$3.24	$0.3213	$3.39	+103.94%
November, 2027	$2.23	$1.61	$3.33	+40.47%
December, 2027	$5.81	$1.81	$10.03	+265.29%

Actinium Pharmaceuticals Inc Stock (ATNM) Price Forecast for 2028

In 2028, Actinium Pharmaceuticals Inc (ATNM) is projected to reach an average price of $4.44, with a high projection of $9.90 and a low estimate of $1.54. This indicates an +179.42% rise from the last price of $1.59.

Month	Average	Low	High	Change from today's price
January, 2028	$6.26	$4.27	$7.94	+293.65%
February, 2028	$5.70	$4.52	$6.49	+258.73%
March, 2028	$6.68	$4.47	$6.97	+320.03%
April, 2028	$8.94	$6.26	$9.63	+462.46%
May, 2028	$4.54	$3.68	$9.90	+185.79%
June, 2028	$4.44	$3.88	$4.84	+179.17%
July, 2028	$4.09	$3.56	$4.81	+157.21%
August, 2028	$3.75	$3.32	$4.52	+136.12%
September, 2028	$2.75	$2.51	$4.05	+72.89%
October, 2028	$2.41	$2.31	$3.18	+51.57%
November, 2028	$1.69	$1.54	$2.48	+6.58%
December, 2028	$2.05	$1.78	$3.42	+28.89%

Actinium Pharmaceuticals Inc Stock (ATNM) Price Forecast for 2029

The 2029 price forecast for Actinium Pharmaceuticals Inc Stock (ATNM) is $2.72 on average, with a high prediction of $6.62 and a low estimate of $0.0728. This represents an +70.89% increase from the previous price of $1.59.

Month	Average	Low	High	Change from today's price
January, 2029	$1.23	$1.15	$2.24	-22.63%
February, 2029	$0.3849	$0.1886	$1.64	-75.79%
March, 2029	$1.28	$0.0728	$1.54	-19.52%
April, 2029	$1.18	$0.4858	$2.21	-25.76%
May, 2029	$1.41	$0.8566	$2.18	-11.62%
June, 2029	$4.70	$1.20	$4.95	+195.59%
July, 2029	$4.08	$2.38	$6.09	+156.65%
August, 2029	$3.19	$2.79	$5.96	+100.34%
September, 2029	$6.18	$3.21	$6.62	+288.69%
October, 2029	$3.77	$3.77	$6.27	+137.17%
November, 2029	$3.64	$3.24	$4.31	+128.66%
December, 2029	$1.57	$1.63	$5.18	-1.04%

Actinium Pharmaceuticals Inc Stock (ATNM) Price Forecast for 2030

Actinium Pharmaceuticals Inc Stock (ATNM) is expected to reach an average price of $1.43 in 2030, with a high forecast of $1.78 and a low forecast of $1.06. This signifies an -9.96% decrease from the last price of $1.59.

Month	Average	Low	High	Change from today's price
January, 2030	$1.47	$1.48	$1.34	-7.63%
February, 2030	$1.47	$1.48	$1.39	-7.30%
March, 2030	$1.40	$1.49	$1.45	-11.99%
April, 2030	$1.68	$1.48	$1.58	+5.56%
May, 2030	$1.85	$1.90	$1.78	+16.59%
June, 2030	$1.59	$1.76	$1.76	-0.06%
July, 2030	$1.74	$1.69	$1.76	+9.32%
August, 2030	$1.29	$1.68	$1.71	-18.65%
September, 2030	$1.55	$1.21	$1.43	-2.36%
October, 2030	$1.22	$1.28	$1.30	-23.41%
November, 2030	$0.8031	$1.06	$0.9917	-49.49%
December, 2030	$1.11	$1.16	$1.10	-30.05%